Commentary about open-label randomized controlled study of ivermectin in mild to moderate COVID-19

Authors

  • Giovanni Meneses Departamento Académico de Medicina Preventivay Salud Pública, Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru

Keywords:

ivermectin, COVID-19

Abstract

Abstract not available

Ibrahim Med. Coll. J. 2020; 14(2): 67-68

Downloads

Download data is not yet available.
Abstract
760
PDF
241

Downloads

Published

2021-04-05

How to Cite

Meneses, G. (2021). Commentary about open-label randomized controlled study of ivermectin in mild to moderate COVID-19. IMC Journal of Medical Science, 14(2), 67–68. Retrieved from https://www.banglajol.info/index.php/IMCJMS/article/view/52833

Issue

Section

Letters to the Editor